Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion

Journal of Immunology

Volumn 189, Issue 1, 2012, Pages 403-410

  Luzina, Irina G ^a,b   Pickering, Edward M ^a   Kopach, Pavel ^a   Kang, Phillip H ^a   Lockatell, Virginia ^a   Todd, Nevins W ^a,b   Papadimitriou, John C ^a   McKenzie, Andrew N J ^c   Atamas, Sergei P ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; MEMBRANE PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN ST2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; FEMALE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GOBLET CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IN VIVO STUDY; LOEFFLER PNEUMONIA; LYMPHOCYTIC INFILTRATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; TH2 CELL;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN BIOSYNTHESIS; PULMONARY FIBROSIS; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN; STEM CELLS; TH2 CELLS;

EID: 84862838199     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200259     Document Type: Article

References (48)

1. Arend, W. P., G. Palmer, and C. Gabay. 2008. IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 223: 20-38. (Pubitemid 351986169)
2. Sims, J. E., and D. E. Smith. 2010. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10: 89-102.
3. Liew, F. Y., N. I. Pitman, and I. B. McInnes. 2010. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10: 103-110.
4. Murphy, G. E., D. Xu, F. Y. Liew, and I. B. McInnes. 2010. Role of interleukin 33 in human immunopathology. Ann. Rheum. Dis. 69(Suppl. 1): i43-i47.
5. Carriere, V., L. Roussel, N. Ortega, D. A. Lacorre, L. Americh, L. Aguilar, G. Bouche, and J. P. Girard. 2007. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 104: 282-287. (Pubitemid 46068023)
6. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490. (Pubitemid 41587888)
7. Lécart, S., N. Lecointe, A. Subramaniam, S. Alkan, D. Ni, R. Chen, V. Boulay, J. Pène, K. Kuroiwa, S. Tominaga, and H. Yssel. 2002. Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface. Eur. J. Immunol. 32: 2979-2987. (Pubitemid 35238191)
8. Hayakawa, M., H. Hayakawa, Y. Matsuyama, H. Tamemoto, H. Okazaki, and S. Tominaga. 2009. Mature interleukin-33 is produced by calpain-mediated cleavage in vivo. Biochem. Biophys. Res. Commun. 387: 218-222.
9. Ohno, T., K. Oboki, N. Kajiwara, E. Morii, K. Aozasa, R. A. Flavell, K. Okumura, H. Saito, and S. Nakae. 2009. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J. Immunol. 183: 7890-7897.
10. Ali, S., D. Q. Nguyen, W. Falk, and M. U. Martin. 2010. Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation. Biochem. Biophys. Res. Commun. 391: 1512-1516.
11. Talabot-Ayer, D., C. Lamacchia, C. Gabay, and G. Palmer. 2009. Interleukin-33 is biologically active independently of caspase-1 cleavage. J. Biol. Chem. 284: 19420-19426.
12. Cayrol, C., and J. P. Girard. 2009. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. USA 106: 9021-9026.
13. Lüthi, A. U., S. P. Cullen, E. A. McNeela, P. J. Duriez, I. S. Afonina, C. Sheridan, G. Brumatti, R. C. Taylor, K. Kersse, P. Vandenabeele, et al. 2009. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31: 84-98.
14. Zhiguang, X., C. Wei, R. Steven, D. Wei, Z. Wei, M. Rong, L. Zhanguo, and Z. Lianfeng. 2010. Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice. Immunol. Lett. 131: 159-165.
15. Préfontaine, D., S. Lajoie-Kadoch, S. Foley, S. Audusseau, R. Olivenstein, A. J. Halayko, C. Lemière, J. G. Martin, and Q. Hamid. 2009. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 183: 5094-5103.
16. Kurokawa, M., S. Matsukura, M. Kawaguchi, K. Ieki, S. Suzuki, M. Odaka, S. Watanabe, T. Homma, M. Sato, M. Yamaguchi, et al. 2011. Expression and effects of IL-33 and ST2 in allergic bronchial asthma: IL-33 induces eotaxin production in lung fibroblasts. Int. Arch. Allergy Immunol. 155(Suppl. 1): 12-20.
17. Le Goffic, R., M. I. Arshad, M. Rauch, A. L'helgoualc'h, B. Delmas, C. Piquet-Pellorce, and M. Samson. 2011. Infection with influenza virus induces IL-33 in murine lungs. Am. J. Respir. Cell Mol. Biol. 45: 1125-1132.
18. Yanaba, K., A. Yoshizaki, Y. Asano, T. Kadono, and S. Sato. 2011. Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Clin. Rheumatol. 30: 825-830.
19. Oshikawa, K., K. Kuroiwa, K. Tago, H. Iwahana, K. Yanagisawa, S. Ohno, S. I. Tominaga, and Y. Sugiyama. 2001. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am. J. Respir. Crit. Care Med. 164: 277-281. (Pubitemid 34001295)
20. Tajima, S., K. Oshikawa, S. Tominaga, and Y. Sugiyama. 2003. The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest 124: 1206-1214. (Pubitemid 37290028)
21. Luzina, I. G., J. C. Papadimitriou, R. Anderson, K. Pochetuhen, and S. P. Atamas. 2006. Induction of prolonged infiltration of T lymphocytes and transient T lymphocyte-dependent collagen deposition in mouse lungs following adenoviral gene transfer of CCL18. Arthritis Rheum. 54: 2643-2655. (Pubitemid 44205027)
22. Pochetuhen, K., I. G. Luzina, V. Lockatell, J. Choi, N. W. Todd, and S. P. Atamas. 2007. Complex regulation of pulmonary inflammation and fibrosis by CCL18. Am. J. Pathol. 171: 428-437. (Pubitemid 47344676)
23. 5 on pulmonary T lymphocytes. Arthritis Rheum. 60: 1530-1539.
24. Luzina, I. G., V. Lockatell, N. W. Todd, A. D. Keegan, J. D. Hasday, and S. P. Atamas. 2011. Splice isoforms of human interleukin-4 are functionally active in mice in vivo. Immunology 132: 385-393.
25. Luzina, I. G., V. Lockatell, N. W. Todd, K. Highsmith, A. D. Keegan, J. D. Hasday, and S. P. Atamas. 2011. Alternatively spliced variants of interleukin-4 promote inflammation differentially. J. Leukoc. Biol. 89: 763-770.
26. Matsushime, H., M. F. Roussel, K. Matsushima, A. Hishinuma, and C. J. Sherr. 1991. Cloning and expression of murine interleukin-1 receptor antagonist in macrophages stimulated by colony-stimulating factor 1. Blood 78: 616-623.
27. Luzina, I. G., K. Highsmith, K. Pochetuhen, N. Nacu, J. N. Rao, and S. P. Atamas. 2006. PKCa mediates CCL18-stimulated collagen production in pulmonary fibroblasts. Am. J. Respir. Cell Mol. Biol. 35: 298-305. (Pubitemid 44353397)
28. Luzina, I. G., N. Tsymbalyuk, J. Choi, J. D. Hasday, and S. P. Atamas. 2006. CCL18-stimulated upregulation of collagen production in lung fibroblasts requires Sp1 signaling and basal Smad3 activity. J. Cell. Physiol. 206: 221-228. (Pubitemid 41740735)
29. Townsend, M. J., P. G. Fallon, D. J. Matthews, H. E. Jolin, and A. N. McKenzie. 2000. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J. Exp. Med. 191: 1069-1076.
30. Komai-Koma, M., D. Xu, Y. Li, A. N. McKenzie, I. B. McInnes, and F. Y. Liew. 2007. IL-33 is a chemoattractant for human Th2 cells. Eur. J. Immunol. 37: 2779-2786. (Pubitemid 47578297)
31. Louten, J., A. L. Rankin, Y. Li, E. E. Murphy, M. Beaumont, C. Moon, P. Bourne, T. K. McClanahan, S. Pflanz, and R. de Waal Malefyt. 2011. Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation. Int. Immunol. 23: 307-315.
32. Nawijn, M. C., G. M. Dingjan, R. Ferreira, B. N. Lambrecht, A. Karis, F. Grosveld, H. Savelkoul, and R. W. Hendriks. 2001. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo. J. Immunol. 167: 724-732. (Pubitemid 32660825)
33. Hayakawa, M., K. Yanagisawa, S. Aoki, H. Hayakawa, N. Takezako, and S. Tominaga. 2005. T-helper type 2 cell-specific expression of the ST2 gene is regulated by transcription factor GATA-3. Biochim. Biophys. Acta 1728: 53-64. (Pubitemid 40409955)
34. Löhning, M., A. Stroehmann, A. J. Coyle, J. L. Grogan, S. Lin, J. C. Gutierrez-Ramos, D. Levinson, A. Radbruch, and T. Kamradt. 1998. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. USA 95: 6930-6935. (Pubitemid 28278084)
35. + T cells: induction of type 2 cytokine production by T1/ST2 cross-linking. J. Immunol. 166: 3143-3150.
36. Liu, X., M. Li, Y. Wu, Y. Zhou, L. Zeng, and T. Huang. 2009. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem. Biophys. Res. Commun. 386: 181-185.
37. Coyle, A. J., C. Lloyd, J. Tian, T. Nguyen, C. Erikkson, L. Wang, P. Ottoson, P. Persson, T. Delaney, S. Lehar, et al. 1999. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J. Exp. Med. 190: 895-902. (Pubitemid 29480818)
38. Walzl, G., S. Matthews, S. Kendall, J. C. Gutierrez-Ramos, A. J. Coyle, P. J. Openshaw, and T. Hussell. 2001. Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology. J. Exp. Med. 193: 785-792. (Pubitemid 32524528)
39. Yang, Q., G. Li, Y. Zhu, L. Liu, E. Chen, H. Turnquist, X. Zhang, O. J. Finn, X. Chen, and B. Lu. 2011. IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells. Eur. J. Immunol. 41: 3351-3360.
40. Joshi, A. D., S. R. Oak, A. J. Hartigan, W. G. Finn, S. L. Kunkel, K. E. Duffy, A. Das, and C. M. Hogaboam. 2010. Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages. BMC Immunol. 11: 52.
41. Smithgall, M. D., M. R. Comeau, B. R. Yoon, D. Kaufman, R. Armitage, and D. E. Smith. 2008. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 20: 1019-1030.
42. Verri, W. A., Jr., A. T. Guerrero, S. Y. Fukada, D. A. Valerio, T. M. Cunha, D. Xu, S. H. Ferreira, F. Y. Liew, and F. Q. Cunha. 2008. IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc. Natl. Acad. Sci. USA 105: 2723-2728. (Pubitemid 351520580)
43. Ali, S., A. Mohs, M. Thomas, J. Klare, R. Ross, M. L. Schmitz, and M. U. Martin. 2011. The dual function cytokine IL-33 interacts with the transcription factor NF-kB to dampen NF-kB-stimulated gene transcription. J. Immunol. 187: 1609-1616.
44. Warner, R. L., L. Beltran, E. M. Younkin, C. S. Lewis, S. J. Weiss, J. Varani, and K. J. Johnson. 2001. Role of stromelysin 1 and gelatinase B in experimental acute lung injury. Am. J. Respir. Cell Mol. Biol. 24: 537-544. (Pubitemid 32442760)
45. Nerusu, K. C., R. L. Warner, N. Bhagavathula, S. D. McClintock, K. J. Johnson, and J. Varani. 2007. Matrix metalloproteinase-3 (stromelysin-1) in acute inflammatory tissue injury. Exp. Mol. Pathol. 83: 169-176. (Pubitemid 47320658)
46. Gosselink, J. V., S. Hayashi,W. M. Elliott, L. Xing, B. Chan, L. Yang, C. Wright, D. Sin, P. D. Paré, J. A. Pierce, et al. 2010. Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 181: 1329-1335.
47. Flechsig, P., B. Hartenstein, S. Teurich, M. Dadrich, K. Hauser, A. Abdollahi, H. J. Gröne, P. Angel, and P. E. Huber. 2010. Loss of matrix metalloproteinase-13 attenuates murine radiation-induced pulmonary fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 77: 582-590.
48. Parker, A. L., S. A. Nicklin, and A. H. Baker. 2008. Interactions of adenovirus vectors with blood: implications for intravascular gene therapy applications. Curr. Opin. Mol. Ther. 10: 439-448.